PLK Inhibitor
Showing 1 - 25 of 7,368
Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)
Recruiting
- Small-cell Lung Cancer
- Small Cell Lung Carcinoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 29, 2022
Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia Trial in Rochester (Biospecimen
Recruiting
- Recurrent Chronic Myelomonocytic Leukemia
- Refractory Chronic Myelomonocytic Leukemia
- Biospecimen Collection
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal
Recruiting
- Borderline Resectable Pancreatic Adenocarcinoma
- +11 more
- Cobimetinib
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Mar 22, 2022
Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Onvansertib
- +3 more
-
Phoenix, Arizona
- +5 more
Dec 15, 2022
Metastatic Colorectal Cancer, KRAS Gene Mutation Trial in United States (Onvansertib, Bevacizumab, FOLFIRI)
Active, not recruiting
- Metastatic Colorectal Cancer
- KRAS Gene Mutation
- Onvansertib
- +2 more
-
Phoenix, Arizona
- +6 more
Nov 10, 2022
Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)
Recruiting
- Sarcoma,Soft Tissue
- Selinexor 20 MG
- Gemcitabine
-
Tenerife, Canarias, Spain
- +10 more
Oct 27, 2023
Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)
Recruiting
- Peripheral T Cell Lymphoma
- Linperlisib in combined with Chidamide
-
Beijing, Beijing/China, China
- +1 more
Oct 9, 2023
Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)
Recruiting
- Cutaneous T-cell Lymphoma
- Linperlisib in combined with Chidamide
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 8, 2023
Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)
Not yet recruiting
- Cervical Cancer
- Anti-PD-1 antibody balstilimab
-
Amsterdam, NetherlandsAmsterdam UMC
Oct 17, 2023
Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)
Recruiting
- Hepatocellular Carcinoma (HCC)
-
Kaohsiung, Taiwan
- +4 more
Mar 14, 2023
Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)
Not yet recruiting
- Differentiated Thyroid Cancer
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri
May 5, 2023
Blood Vessel Function in Postmenopausal Women With Breast Cancer
Active, not recruiting
- Breast Cancer
- anastrozole
- +3 more
-
Rochester, MinnesotaMayo Clinic
Jan 17, 2023
Chronic Kidney Disease Trial (Part A - Lorundrostat QD + Dapaglifozin QD, Part A - Lorundrostat QD, Part B - Lorundrostat QD
Not yet recruiting
- Chronic Kidney Disease
- Part A - Lorundrostat QD + Dapaglifozin QD
- +2 more
- (no location specified)
Nov 27, 2023
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,
Not yet recruiting
- Adenoid Cystic Carcinoma
- +2 more
- CB-103
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 14, 2023
Healthy Trial in Biberach (BI 1810631, Itraconazole)
Recruiting
- Healthy
- BI 1810631
- Itraconazole
-
Biberach, GermanyHumanpharmakologisches Zentrum Biberach
Apr 27, 2023
Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor Trial in Hangzhou (Tegoprazan, Esomeprazole)
Active, not recruiting
- Vonoprazan
- +2 more
-
Hangzhou, Zhejiang, ChinaHangzhou first people's Hospital
Dec 2, 2022
Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)
Active, not recruiting
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Ravulizumab
-
Aurora, Colorado
- +19 more
Nov 16, 2022
Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor Trial in Hangzhou (Vonoprazan Tablets, Amoxicillin Capsules,
Recruiting
- Vonoprazan
- +2 more
- Vonoprazan Tablets
- +2 more
-
Hangzhou, Zhejiang, ChinaHangzhou first people's Hospital
Nov 23, 2022